Catarina Edfjäll
Geen lopende functies
Vermogen: - $ op 31-05-2024
Profiel
Catarina Edfjäll formerly worked at The Cancer Drug Development Forum, as Director from 2008 to 2012, International Collaboration On Rare Diseases & Orphan Drugs, as Director from 2014 to 2021, ObsEva SA, as Independent Director from 2021 to 2024, and CSL Behring AG, as Global Head-Regulatory Affairs from 2013 to 2019.
Dr. Edfjäll received her doctorate degree from the University of Basel and graduate degree from the University of Strasbourg.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
OBSEVA SA
-.--% | 24-03-2023 | 0 ( -.--% ) | - $ | 31-05-2024 |
Eerdere bekende functies van Catarina Edfjäll
| Bedrijven | Functie | Einde |
|---|---|---|
| OBSEVA SA | Directeur/Bestuurslid | 18-03-2024 |
| International Collaboration On Rare Diseases & Orphan Drugs | Directeur/Bestuurslid | 01-01-2021 |
CSL Behring AG
 CSL Behring AG BiotechnologyHealth Technology Part of CSL Ltd., CSL Behring AG is a Swiss company that develops biological products. The company is based in Bern, Switzerland. | Algemeen Adviseur | 01-01-2019 |
| The Cancer Drug Development Forum | Directeur/Bestuurslid | 01-01-2012 |
Opleiding van Catarina Edfjäll
| University of Basel | Doctorate Degree |
| University of Strasbourg | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| OBSEVA SA | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
| The Cancer Drug Development Forum | |
| International Collaboration On Rare Diseases & Orphan Drugs | |
CSL Behring AG
CSL Behring AG BiotechnologyHealth Technology Part of CSL Ltd., CSL Behring AG is a Swiss company that develops biological products. The company is based in Bern, Switzerland. | Health Technology |
